Insperity (NSP)
(Delayed Data from NYSE)
$87.74 USD
-1.17 (-1.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $87.79 +0.05 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$87.74 USD
-1.17 (-1.32%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $87.79 +0.05 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Zacks News
Zacks Industry Outlook Highlights Insperity, Kforce and Cross Country Healthcare
by Zacks Equity Research
Insperity, Kforce and Cross Country Healthcare have been highlighted in this Industry Outlook article.
3 Staffing Services Stocks to Watch Amid Industry Headwinds
by Zacks Equity Research
The Zacks Staffing industry stands to benefit from the resumption of business activities, increased dependency on technology and benefits related to the ongoing hybrid working model. NSP, KFRC and CCRN are well poised to witness a demand surge.
Zacks.com featured highlights Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger
by Zacks Equity Research
Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger have been highlighted in this Screen of The Week article.
5 Top-Ranked Dividend Growth Stocks to Buy Now
by Sweta Killa
Insperity (NSP), Microchip Technology (MCHP), Darden Restaurants (DRI), Dr. Reddys (RDY) and W.W. Grainger (GWW) could be compelling picks for investors.
Find 'Strong Buy' Stocks that Boast Impressive Return on Equity
by Benjamin Rains
Instead of trying to chase some of the big tech names and high-growth stocks that have surged in 2023, investors might be better served to buy companies that have proven they can turn assets into profits, especially with a possible recession looming.
Insperity, Inc. (NSP) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Insperity, Inc. (NSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include Lamb Weston, NeoGenomics, Surrozen, KE Holdings and Insperity
by Zacks Equity Research
Lamb Weston, NeoGenomics, Surrozen, KE Holdings and Insperity are part of the Zacks Screen of the Week article.
5 Top Stocks Likely to Come Up With Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Lamb Weston (LW), NeoGenomics (NEO), Surrozen (SRZN), KE Hodlings (BEKE) and Insperity (NSP).
Mastercard's (MA) New Offering to Boost Cross-Border Services Suite
by Zacks Equity Research
Mastercard (MA) introduces Cross-Border Services Express so that consumers and businesses of all sizes can benefit from enhanced and hassle-free cross-border payments.
Here's What Could Help Insperity, Inc. (NSP) Maintain Its Recent Price Strength
by Zacks Equity Research
Insperity, Inc. (NSP) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Best Income Stocks to Buy for April 12th
by Zacks Equity Research
PPG and NSP made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 12, 2023.
Insperity (NSP) Gains From Growing PEO Industry, Costs High
by Zacks Equity Research
Rising number of worksite employees and pertaining employee-friendly behavior support Insperity (NSP) despite rising costs.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain Insperity (NSP) Stock in Your Portfolio
by Zacks Equity Research
Insperity's (NSP) business is currently benefiting from strength in the professional employer organization or the PEO industry.
Insperity (NSP) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Insperity (NSP) fourth-quarter 2022 earnings and revenues surge year over year.
Insperity, Inc. (NSP) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Insperity, Inc. (NSP) delivered earnings and revenue surprises of 32.97% and 1.03%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insperity, Inc. (NSP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Insperity, Inc. (NSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Insperity, Kforce and Cross Country Healthcare
by Zacks Equity Research
Insperity, Kforce and Cross Country Healthcare have been highlighted in this Industry Outlook article.
3 Stocks to Watch From the Promising Staffing Services Industry
by Zacks Equity Research
Re-opening of the global economy, increased dependency on technology and benefits of the ongoing hybrid working model should aid the Zacks Staffing industry. NSP, KFRC and CCRN are well poised to witness a demand surge.
Insperity (NSP) Gains 14.4% in the Past 6 Months: Here's How
by Zacks Equity Research
Top-line growth as well as continuous investor-friendly steps boost Insperity (NSP).
4 Business Services Stocks Most Wall Street Analysts Are Bullish About
by Zacks Equity Research
RTO, FUTU, INST and NSP are poised to benefit in 2023 and beyond with healthy fundamentals and solid Zacks Rank.
Zacks.com featured highlights include Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block
by Zacks Equity Research
Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block are part of the Zacks Screen of the Week.
Here's Why Investors Should Buy Insperity (NSP) Stock Now
by Zacks Equity Research
Pro-investor steps and the growing PEO industry are aiding Insperity's (NSP) stock.
5 Top-Ranked Dividend Growth Stocks for 2023
by Sweta Killa
Archer-Daniels-Midland (ADM), Cardinal Health (CAH), Insperity (NSP), Deere & Company (DE), and H&R Block (HRB) could be compelling picks for 2023.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.